Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

9C1Y

Structure of human neuronal nitric oxide synthase R354A/G357D mutant heme domain in complex with 7-((3-(((4-(6-aminopyridin-2-yl)butyl)amino)methyl)phenoxy)methyl)quinolin-2-amine

9C1Y の概要
エントリーDOI10.2210/pdb9c1y/pdb
分子名称Nitric oxide synthase, brain, PROTOPORPHYRIN IX CONTAINING FE, 7-{[3-({[4-(6-aminopyridin-2-yl)butyl]amino}methyl)phenoxy]methyl}quinolin-2-amine, ... (6 entities in total)
機能のキーワードnitric oxide synthase inhibitor, heme enzyme, oxidoreductase
由来する生物種Homo sapiens (human)
タンパク質・核酸の鎖数4
化学式量合計200846.62
構造登録者
Li, H.,Poulos, T.L. (登録日: 2024-05-29, 公開日: 2025-06-11, 最終更新日: 2025-08-06)
主引用文献Weerawarna, P.M.,Li, H.,Rathnayake, A.D.,Hardy, C.D.,Poulos, T.L.,Silverman, R.B.
A Tetrahydrobiopterin-Displacing Potent Neuronal Nitric Oxide Synthase Inhibitor with an Unprecedented Binding Mode.
Acs Med.Chem.Lett., 16:651-659, 2025
Cited by
PubMed Abstract: Nitric oxide synthase (NOS) is a pivotal enzyme that regulates various physiological processes, and the dysregulation of neuronal NOS (nNOS) is implicated in neurodegenerative diseases. In our efforts to leverage existing X-ray crystallography data to develop novel aminoquinoline-pyridine hybrid inhibitors and evaluate their inhibitory activities and interactions with NOS isoforms, we identified compounds and as potent human nNOS inhibitors ( = 38 and 22 nM, respectively). Notably, compound displayed an unprecedented binding mode, displacing the essential cofactor tetrahydrobiopterin (HB). Furthermore, compound exhibited excellent selectivity, with a 900-fold preference for human nNOS over human eNOS, making it one of the most potent and selective aminoquinoline-based nNOS inhibitors reported to date. Herein we present our inhibitor design rationale, the synthesis, and the biochemical/physical evaluation of binding along with X-ray crystallographic studies with three NOS isoforms, providing detailed insights into the observed potency and selectivity of these inhibitors.
PubMed: 40236557
DOI: 10.1021/acsmedchemlett.5c00062
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2.3 Å)
構造検証レポート
Validation report summary of 9c1y
検証レポート(詳細版)ダウンロードをダウンロード

252456

件を2026-04-22に公開中

PDB statisticsPDBj update infoContact PDBjnumon